Pressure BioSciences (PBI) (NASDAQ:PBIO) is a company operating in the life sciences market, whose pressure cycling technology (PCT) used to extract cell components has a myriad of potential target industries, and according to CEO Richard T. Schumacher, is among the most under-appreciated businesses listed on the Nasdaq today, with enormous growth potential.
Pressure BioSciences’ core pressure cycling technology to become scientific “investigators choice”
This entry was posted in New ID Technologies. Bookmark the permalink.